Previous Article | Next Article 
Journal of Clinical Microbiology, May 2000, p. 1797-1803, Vol. 38, No. 5
0095-1137/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
Oxygen and Carbon Dioxide Regulation of Toxic Shock Syndrome
Toxin 1 Production by Staphylococcus aureus MN8
Jeremy M.
Yarwood and
Patrick M.
Schlievert*
Department of Microbiology, University of
Minnesota Medical School, Minneapolis, Minnesota 55455
Received 16 July 1999/Returned for modification 19 November
1999/Accepted 11 February 2000
 |
ABSTRACT |
The production of toxic shock syndrome toxin 1 (TSST-1) by
Staphylococcus aureus MN8 exposed to a range of oxygen
concentrations (0 to 21% [vol/vol]) was examined in batch and
thin-film cultures. The response of S. aureus to this range
of oxygen concentrations was studied in the absence and in the presence
of 7% (vol/vol) carbon dioxide. In the absence of carbon dioxide,
TSST-1 production in batch cultures increased from negligible levels in
the presence of oxygen concentrations of 1% or less to 500 ng/ml in
the presence of 2% oxygen and then decreased to 70 ng/ml or less in
the presence of oxygen concentrations of 6% and higher. In the
presence of carbon dioxide, however, toxin production increased from
negligible levels in the presence of 1% oxygen to 1,900 ng/ml in the
presence of 21% oxygen. In thin-film cultures, TSST-1 production
increased from nearly undetectable levels under anaerobic conditions to 1 and 10 µg/ml under 21% oxygen in the absence and presence of carbon dioxide, respectively. This study demonstrates the controlling effects of both oxygen and carbon dioxide on TSST-1 production.
 |
INTRODUCTION |
Toxic shock syndrome toxin 1 (TSST-1) is a pyrogenic toxin superantigen produced by many pathogenic
strains of Staphylococcus aureus. TSST-1 stimulates the
proliferation of both CD4+ and CD8+ T cells
(5) that display particular V
elements in their T-cell receptors (11). TSST-1 is associated with staphylococcal
toxic shock syndrome (TSS) and is considered to be the cause of nearly all cases of menstrual TSS and at least 50% of nonmenstrual cases (3). TSS is a severe multisystem condition characterized by high fever, rash, hypotension, and skin desquamation. TSST-1 has also
been implicated in recalcitrant, erythematous, desquamating syndrome,
which affects AIDS patients (6). TSST-1 is produced by
organisms present in 60 to 70% of patients with Kawasaki syndrome, an
illness that shares many features with TSS and that is typically seen
in children under 4 years of age (12). The role of TSST-1 in
Kawasaki syndrome remains controversial, however.
Numerous studies have demonstrated the importance of oxygen tension in
the regulation of TSST-1 production by S. aureus. Excess aeration of cultures, as well as complete anaerobiosis, resulted in
repression of TSST-1 production, while microaerobic environments appeared to stimulate toxin expression (15, 21, 24). It has
been suggested that elevated vaginal oxygen levels associated with the
insertion of a tampon stimulate the production of TSST-1 (17). Wagner et al. (23) demonstrated that the
vaginal environment is normally anaerobic and that insertion of a
tampon dramatically increased the oxygen level on the vaginal mucosal
surface. Following tampon insertion, oxygen levels slowly declined
throughout the observation period of 8 h.
The response of S. aureus, however, to the full spectrum of
physiologically relevant oxygen tensions has never been completely and
carefully examined in cultures that mimic physical conditions in vivo.
What oxygen levels result in maximum toxin levels and what oxygen
levels effectively shut off toxin production have remained unanswered
questions. In the study described here, we examined the production of
TSST-1 by S. aureus in the presence of a range of oxygen
levels relevant to in vivo conditions and discuss their implications
for antistaphylococcal chemotherapy. We also characterize the response
of S. aureus to various oxygen levels in the presence or
absence of carbon dioxide. We introduce the use of thin-film culture to
examine the response of S. aureus to oxygen and carbon dioxide.
 |
MATERIALS AND METHODS |
Bacterial strain and growth conditions.
The S. aureus strain used in this study, MN8, was isolated from the
vagina of a TSS patient (4). Strains were grown in beef
heart medium prepared as described previously (4) with 1%
glucose-phosphate buffer (60 g of glucose, 40 g of
NaHCO3, 40 g of NaCl, 30 g of
Na2HPO4, and 4 g of
L-glutamine in 1 liter of H2O) in either batch
or thin-film cultures. For batch cultures, 300 ml of medium in 2-liter
flasks was inoculated with S. aureus to achieve an initial
density of 107 CFU/ml. Batch cultures were incubated at
37°C while being continuously stirred with a Teflon-coated magnetic
stir bar and were flushed at a rate of approximately 5 liters/min with
a gas mixture (Praxair, St. Louis, Mo.). The gas mixtures contained a
constant percentage of oxygen balanced with nitrogen and, when
indicated, 7% carbon dioxide. The effect of stirring in the batch
cultures was to entrain completely the atmosphere throughout the
culture in the form of small bubbles, exposing the entire culture to
atmospheric oxygen levels. In tests with an oxygen probe (model 5300;
YSI Inc., Yellow Springs, Ohio), the oxygen concentrations in the
headspace of the batch culture container were found to be constant
throughout the incubation period, while the dissolved oxygen levels in
the liquid medium slowly declined to undetectable levels during
exponential growth of the bacteria. Batch cultures were incubated for 6 to 7 h when no carbon dioxide was present or 8 h when 7%
carbon dioxide was included in the gas mixture. Samples were removed
from the culture at regular time intervals, and readings of the optical density at 600 nm were taken and cell counts were determined prior to
ethanol treatment of the culture samples. Proteins were precipitated and cells were killed in 4 volumes of ethanol for a minimum of 12 h. Precipitation by this method has been shown to be complete, and the
removal of bacteria prior to treatment with ethanol is not necessary to
quantify toxin production (16, 17). The mixtures were
centrifuged at 500 × g for 10 min, the supernatant was
removed, and the pellet was partially desiccated to remove excess
liquid. The pellets were resuspended in 1 ml of phosphate buffer
solution containing 1.0% fetal calf serum and 0.05% Tween 20 and were
centrifuged at approximately 500 × g for 5 min to
remove insoluble cell debris in the preparation for determination of
TSST-1 concentrations by enzyme-linked immunosorbent assay (ELISA).
For thin-film cultures, 1 ml of medium containing 107
S. aureus CFU was placed on the bottom of polystyrene petri
dishes (100 by 15 mm; Fisher Scientific, Pittsburgh, Pa.) and was held
in place with squares (4 by 4 cm) of polyethylene mesh. The thin-film cultures were placed in sealed, humidified Plexiglas cell culture chambers (as described by Mishell and Mishell [13];
internal dimensions, 20 by 26 by 7.5 cm). The chambers had inlet and
exit ports for flushing with the indicated gas mixtures before sealing. The thin-film cultures were incubated at 37°C for 24 h. After removal of the cultures from the chambers, the cells were resuspended by agitation in 3 ml of Todd-Hewitt broth (Difco Laboratories, Detroit,
Mich.). Two milliliters of this suspension was immediately treated with
8 ml (4 volumes) of ethanol, and the mixture was incubated at room
temperature overnight to precipitate the toxin. As described above,
removal of cells prior to ethanol treatment was not necessary for
quantitative toxin detection. The mixture was centrifuged at
500 × g for 10 min, the supernatant was removed, and
the pellet was desiccated to remove excess liquid. The pellets were
resuspended in 1 ml of phosphate buffer solution containing 1.0% fetal
calf serum and 0.05% Tween 20 and was centrifuged at approximately
500 × g for 5 min to remove insoluble cell debris in
preparation for determination of TSST-1 concentrations by ELISA.
TSST-1 detection.
To measure TSST-1 production, we used a
previously described double-antibody sandwich ELISA (7) with
minor modifications. Ninety-six-well microtiter plates (NUNC, Roskilde,
Denmark) were coated with highly specific rabbit anti-TSST-1 serum in
carbonate buffer (0.05M NaCO3 [pH 9.6]) and dried
overnight. The wells were washed three times with phosphate buffer
solution (1.9 mM NaH2PO4, 3.1 mM
NaHPO4, 0.15 M NaCl), 0.05% Tween 20, and 1% fetal calf serum (PTF). Diluted toxin samples (100 µl) were added to the wells,
and the plates were incubated for 1.5 h at room temperature. The
wells were again washed three times with PTF. A total of 100 µl of a
1:300 dilution in PTF of rabbit anti-TSST conjugated with a horseradish
peroxidase label (Toxin Technologies, Sarasota, Fla.) was then added to
each well, and the plates were incubated for 1.5 h at room
temperature. The wells were washed with PTF three times. Detection
substrate (100 µl) (1% [wt/vol] o-phenylenediamine and
0.1% [vol/vol] H2O2 in citrate-phosphate
buffer [0.7 M citric acid, 0.3 M Na2HPO4, pH
5.0]) was added to each well, and the plates were incubated until a
color change was observed. The reaction was stopped by the addition of
12.5% H2SO4. Colorimetric reactions were
detected with a microtiter plate reader (EL 340; Bio-Tek Instruments).
TSST-1 concentrations were determined by comparing the absorbance
readings for wells that contained samples to those for wells that
contained a dilution series of control TSST-1 whose concentration was
known. The dilution series of control TSST-1 was included on each
microtiter plate. We have consistently been able to detect TSST-1
concentrations as low as 1 ng/ml using this method.
Control TSST-1 for establishing the standard curve was prepared by
ethanol precipitation of cell cultures, resolubilization in
H2O, centrifugation at 500 × g to remove
insoluble cell debris, and successive thin-layer isoelectric focusing
in pH gradients of 3 to 10 and then 6 to 8 (4). The TSST-1
preparation was homogeneous when tested by sodium dodecyl
sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) as described by
Laemmli (9) with discontinuous 10% acrylamide gels. Control
TSST-1 thus prepared has been determined to be homogeneous when
subjected to SDS-PAGE and silver staining, and there is no evidence of
contamination when the prepared toxin is subjected to automated
sequencing. These preparations have also been satisfactory for the
preparation of crystals for structure analysis with resolution to 1.8 Å.
To determine our ability to recover TSST-1 from staphylococcal
cultures, purified TSST-1 was added to a culture of a TSST-1-negative strain (S. aureus RN4220) to achieve a final concentration
of 1.00 µg/ml. The sample was ethanol precipitated and resolubilized in PTF, and insoluble cell debris was removed and subjected to the
ELISA as described above. The ELISA indicated a TSST-1 concentration of
1.07 µg/ml, or a recovery of 107%.
 |
RESULTS |
Both batch and thin-film cultures were exposed to an atmospheric
oxygen range of 0 to 21% (vol/vol) on the basis of the observation that vaginal oxygen concentrations are normally nearly anaerobic and
will not exceed ambient oxygen concentrations (21%) upon insertion of
a tampon (23).
Batch cultures.
Batch cultures were incubated under continuous
gas flow at 37°C until both the cultures had passed postexponential
phase and the maximum rate of toxin production was observed. For batch
cultures incubated in oxygen and nitrogen mixtures only, these
conditions were observed at approximately 6 h. Batch cultures
incubated in atmospheres containing 7% carbon dioxide, in addition to
oxygen and nitrogen mixtures, were allowed to grow for 8 h until
the maximum rate of toxin production was observed. As observed by comparing Fig. 1A and
2A, toxin production by S. aureus incubated in gas mixtures that contained no carbon dioxide
was initiated at least 1 h earlier than that in cultures incubated
under oxygen balanced with nitrogen and carbon dioxide, supporting the
decision to allow the latter to incubate longer. Although minimal toxin was made after the 6- and 8-h time periods reflected in Fig. 1 and 2,
respectively, cultures incubated for additional periods of time do not
reflect any change in relative toxin production in the presence of
different percentages of oxygen.

View larger version (14K):
[in this window]
[in a new window]
|
FIG. 1.
TSST-1 production by S. aureus MN8 in batch
cultures flushed with gas mixtures containing various oxygen
concentrations balanced with nitrogen. (A) Time course measurements of
TSST-1 production in each batch culture. (B) Concentration of TSST-1 in
each batch culture at 6 h. Data are means ± standard errors
of the means of triplicate ELISA readings for each time point. Toxin
production was measured in at least two independent batch cultures at
each oxygen concentration, with similar results.
|
|

View larger version (13K):
[in this window]
[in a new window]
|
FIG. 2.
TSST-1 production by S. aureus MN8 in batch
cultures flushed with gas mixtures containing various oxygen
concentrations balanced with nitrogen and 7% carbon dioxide. (A) Time
course measurements of TSST-1 production in each batch culture. (B)
Concentration of TSST-1 in each batch culture at 8 h. Data are
means ± standard errors of the means of triplicate ELISA readings
for each time point. Toxin production was measured in at least two
independent batch cultures at each oxygen concentration, with similar
results.
|
|
For all batch cultures, the rate of toxin production was highest during
late exponential and postexponential phases and decreased as cultures
progressed into stationary phase. The final pH of the cultures ranged
from 6.4 to 7.4.
(i) Batch cultures without carbon dioxide.
For batch cultures
incubated in the presence of oxygen balanced with nitrogen alone,
S. aureus began toxin production 3 to 3.5 h after
inoculation of 107 CFU/ml of medium (Fig. 1A). This
initiation of toxin production corresponded to cell densities of
~109 CFU/ml. Toxin production at between 6 and 7 h
was negligible for cultures incubated in the presence of 0.5, 1, 4, 6, and 21% oxygen. We did not assess TSST-1 production at 7 h in the
culture with 2% oxygen; by 6 h toxin production was significantly
higher in this culture than in all the other cultures. Total TSST-1
production by S. aureus in batch cultures was negligible
under anaerobic conditions, peaked (500 ng/ml) in the presence of 2%
oxygen, and declined to only 70 ng/ml in the presence of 6%
atmospheric oxygen levels (Fig. 1B). A representative growth curve and
a time course measurement of toxin production are shown in Fig.
3. We have chosen to express toxin levels
as the amount of TSST-1 produced per milliliter of culture, as the
effect on the host will primarily be determined by total toxin levels
and not the total amount of toxin produced per cell. With the exception
of the batch culture grown in the presence of 0.5% oxygen, however,
all cultures demonstrated nearly identical growth patterns and reached
similar cell densities.

View larger version (14K):
[in this window]
[in a new window]
|
FIG. 3.
Growth curve and time course measurement of TSST-1
production by S. aureus MN8 representative of cultures
incubated in the presence of oxygen balanced with nitrogen. The data
shown here are for the batch culture incubated in the presence of 6%
oxygen balanced with nitrogen. All cultures, with the exception of the
culture incubated in the presence of 0.5% oxygen, exhibited similar
growth patterns and toxin production profiles. TSST-1 production data
are means ± standard errors of the means of triplicate ELISA
readings for each time point.
|
|
(ii) Batch cultures with carbon dioxide.
In batch cultures
incubated in the presence of 7% carbon dioxide, S. aureus
initiated toxin production 4 to 4.5 h after inoculation (Fig. 2A),
1 h later than did S. aureus incubated without carbon dioxide. In addition, S. aureus responded to oxygen levels
that increased from 0 to 21% by producing increasing amounts of TSST-1 (40 to 1,900 ng/ml, respectively) (Fig. 2B). Cultures incubated in the
presence of oxygen balanced with nitrogen and carbon dioxide also
exhibited highly similar growth patterns, and initiation of toxin
production corresponded to densities of ~109 CFU/ml. A
representative growth curve and a time course measurement of toxin
production are shown in Fig. 4.

View larger version (14K):
[in this window]
[in a new window]
|
FIG. 4.
Growth curve and time course measurement of TSST-1
production by S. aureus MN8 representative of cultures
incubated in the presence of oxygen balanced with nitrogen and 7%
carbon dioxide. The data shown here are for the batch culture incubated
in the presence of 8% oxygen balanced with nitrogen and 7% carbon
dioxide. All cultures, with the exception of the culture incubated in
the presence of 1% oxygen, exhibited similar growth patterns and toxin
production profiles. TSST-1 production data are means ± standard
errors of the means of triplicate ELISA readings for each time point.
|
|
(iii) Batch cultures with controlled pH.
Decreasing levels of
oxygen result in slightly lower pH levels, likely due to the buildup of
by-products of homolactic fermentation by S. aureus. It was
possible that, for batch cultures incubated in the presence of carbon
dioxide-containing gas mixtures, lower pH conditions resulted in
decreased levels of dissolved carbon dioxide and thus lower levels of
TSST-1 production. To address this possibility, we conducted a set of
batch cultures identical to those described earlier (including batch
cultures in the presence of 7% carbon dioxide), except that the pH was
maintained at 7.4 to 7.5 with 10 N NaOH. As expected, TSST-1 production
remained virtually undetectable under anaerobic conditions and reached 2 µg/ml in the presence of 8% oxygen (data not shown).
Thin films.
Staphylococci grown in thin-film cultures formed a
visible, opaque film covering the area (4 by 4 cm) of the petri dish.
Without carbon dioxide, the production of TSST-1 by S. aureus in these cultures increased as oxygen levels were increased
from 0 to 21% (Fig. 5). Cell densities
were highly similar in these cultures, with an average of 3.6 × 109 CFU/ml. In the presence of carbon dioxide, TSST-1
production began to level off in the presence of approximately 8%
oxygen and remained high in the presence of oxygen at up to 21% (Fig. 5). Cell densities ranged from 2.3 × 109 CFU/ml under
anaerobic conditions to 5.8 × 109 CFU/ml in the
presence of 21% oxygen. TSST-1 production was significantly enhanced
in the presence of carbon dioxide (approximately 1 log unit).

View larger version (10K):
[in this window]
[in a new window]
|
FIG. 5.
TSST-1 production by S. aureus MN8 in
thin-film cultures incubated in atmospheres containing various oxygen
levels balanced with nitrogen only or with nitrogen and 7%
CO2. TSST-1 concentrations are shown for cultures incubated
for 24 h in chambers initially flushed with the indicated gas
mixture and then sealed. Data are means ± standard errors of the
means of values from three separate thin-film cultures for which
triplicate ELISA readings were performed for each culture.
|
|
 |
DISCUSSION |
TSS emerged as a recognized disease in the late 1970s and early
1980s. Early in the study of TSS, a correlation between the use of
certain types of tampons and incidence of the disease was demonstrated
(19). Numerous studies have attempted to determine the
nature of this association. In 1983, our laboratory proposed that the
presence of oxygen in the vaginal environment played a pivotal role in
the induction of TSST-1 production by S. aureus (17). Several studies have shown that elevated oxygen,
carbon dioxide, and protein levels, along with a relatively neutral pH, are required for TSST-1 production by S. aureus (8, 17,
24). Todd et al. (22) showed that altering any of
these conditions greatly reduced the amount of TSST-1 synthesized by
S. aureus in vitro and, furthermore, that these conditions
are present in patients who experience TSS. Previous studies have not
thoroughly examined the role of oxygen in the regulation of TSST-1
production, however, across the entire range of oxygen concentrations
relevant to in vivo conditions. In this study, we approximate in vivo
conditions using a high-protein medium (beef heart) at neutral pH and
controlled levels of carbon dioxide and oxygen. We fully characterize
TSST-1 production by S. aureus exposed to the full range of
oxygen concentrations expected to occur in vivo (0 to 21% [vol/vol]
oxygen) in the presence and absence of carbon dioxide.
Both oxygen and carbon dioxide exhibit controlling effects on TSST-1
production in batch and thin-film cultures. In both culture types,
anaerobiosis led to a reduction in the level of toxin production to
nearly undetectable levels (Fig. 1B, 2B, and 5). Similarly, batch
cultures incubated without carbon dioxide in the presence of oxygen
levels above 6% exhibited greatly reduced levels of toxin production
(Fig. 1B). In contrast, the presence of carbon dioxide in either the
batch or the thin-film cultures greatly increased the level of TSST-1
production (Fig. 2B and 5). This is consistent with previous studies
that showed that both elevated oxygen and elevated carbon dioxide
levels were required for significant toxin production (8,
22). (TSST-1 production remained high even in the presence of
normal atmospheric levels of oxygen [21%] in the presence of carbon
dioxide. This suggests that previous studies that demonstrated an
inhibitory effect of excess aeration [15, 24] either
maintained culture oxygen levels well above those for cultures in our
study or lacked sufficient carbon dioxide concentrations in the
cultures.) These observations suggest sensory mechanisms that act in
the regulation of virulence factors in S. aureus.
Wagner et al. (23) showed that carbon dioxide levels on the
vaginal surface recovered from near atmospheric levels (<1% [vol/vol]) to normal in vivo levels (5 to 7% [vol/vol]) within a
half hour after insertion of a tampon, whereas oxygen levels remained
well above normal in vivo levels for the entire 8-h observation period.
This suggests that vaginal S. aureus will encounter both elevated carbon dioxide and oxygen levels concurrently, conditions which this study demonstrates are optimal for TSST-1 production.
It is not readily apparent why the thin-film cultures responded
differently than the batch cultures to various oxygen levels when
carbon dioxide was not present (Fig. 1B and 5). At least two factors
might be responsible for the observed differences in the response to
oxygen levels. First, the physical environments of the batch and
thin-film cultures are quite different. Unlike the constantly stirred
cells in the batch culture, which are evenly exposed to atmospheric
gases, the relatively stationary cells of the thin films are possibly
exposed to concentration gradients of oxygen and carbon dioxide. Cells
near the surface of the bacterial film are exposed to atmospheric
levels of these gasses, while cells closer to the polystyrene base may
experience reduced oxygen and elevated carbon dioxide levels due to the
aerobic metabolism of cells nearer the surface. Second, the batch
cultures were continuously flushed with gas mixtures, whereas the
thin-film cultures were placed into chambers initially flushed with the
gas mixture and then sealed for the duration of the experiment.
Atmosphere replacement may have prevented the accumulation of some
metabolic by-products in the batch cultures, while lack of atmosphere
replacement allowed accumulation of by-products in the thin-film
cultures. This accumulation may have significantly altered the response
of S. aureus in the thin-film cultures by inducing toxin
production in the presence of high oxygen levels.
Oxygen-scavenging agents might make effective antitoxigenic compounds,
as anaerobic conditions inhibit TSST-1 production by S. aureus. It would be necessary, however, to find one that is both
nontoxic to humans and a particularly effective scavenging agent, as
even low levels of oxygen permit toxin production. A more effective
approach to combating staphylococcal infection might be to target the
oxygen-sensing mechanism that staphylococci use to regulate virulence
factor production. It is not difficult to envision a two-component
histidine kinase (HK)-response regulator (RR) pair that is sensitive to
oxygen levels and that interacts with S. aureus global
regulators of virulence factors, including toxins. A search of the
S. aureus genome databases at TIGR and at the University of
Oklahoma with a TBlastN search program (1) revealed the
presence of putative homologs to the ResDE HK-RR system that has been
implicated in global regulation of aerobic and anaerobic respiration in
Bacillus subtilis (14, 20). The putative S. aureus RR (PorA) is 68% identical to ResD, while the putative
S. aureus HK (PorB) is 34% identical to ResE. The C
terminus of PorB, which contains the conserved regions integral to HK
activity, is 45% identical to the ResE C-terminal region. The N
terminus has less identity (26%) with the corresponding region in
ResE, but this region contains transmembrane helices that are less
highly conserved among members of the HK family. We have confirmed the presence of these ResDE homolog genes in MN8 using PCR methods. Our
laboratory is investigating the role of this putative two-component system in the control of virulence factors in S. aureus.
Indeed, the targeting of two-component systems has been shown to be
effective against gram-positive pathogens, including
methicillin-resistant S. aureus and vancomycin-resistant
Enterococcus faecium (2, 10). It is conceivable
that such a targeted drug may inhibit oxygen sensing by staphylococci
through two-component systems and thus prevent toxin production.
Although these specialized drugs remain toxic to humans, future efforts
are likely to produce safe and effective compounds for use in
antistaphylococcal chemotherapy. Glycerol monolaurate has also been
shown to have antitoxigenic effects, while it has only weak
antimicrobial action (18). A possible mechanism of glycerol
monolaurate, which acts at the lipid-water interface, is to interfere
with the activity of membrane-bound sensor proteins that are used by
S. aureus and that sense environmental conditions and
regulate toxin production. Inhibition of toxin production would reduce
systemic disorders in patients, while they would help to prevent
further spread of the organism. Treatment with combinations of drugs
that interfere with staphylococcal environmental sensing mechanisms and
standard antibiotics may provide an effective two-pronged approach by
quickly eliminating toxin production and clearing the organism from the patient.
 |
ACKNOWLEDGMENTS |
This study was supported by a research grant from The Procter and
Gamble Co. J.M.Y. was supported by a Howard Hughes Medical Institute
Predoctoral Fellowship in the Biological Sciences and a research grant
from the National Institute of Allergy and Infectious Diseases (grant AI22159).
We thank John McCormick for special assistance in developing laboratory
techniques. We gratefully acknowledge the Staphylococcus aureus Genome Project and B. A. Roe, A. Dorman, F. Z. Najar, S. Clifton, and J. Iandolo, who received funding from the
National Institutes of Health and the Merck Genome Research Institute.
 |
FOOTNOTES |
*
Corresponding author. Mailing address: Department of
Microbiology, Medical School, University of Minnesota, Box 196 FUMC, 420 Delaware St. SE, Minneapolis, MN 55455. Phone: (612) 624-9471. Fax:
(612) 626-0623. E-mail: pats{at}lenti.med.umn.edu.
 |
REFERENCES |
| 1.
|
Altschul, S. F.,
T. L. Madden,
A. A. Schaffer,
J. Zhang,
Z. Zhang,
W. Miller, and D. J. Lipman.
1997.
Gapped BLAST and PSI-BLAST: a new generation of protein database search programs.
Nucleic Acids Res.
25:3389-3402[Abstract/Free Full Text].
|
| 2.
|
Barrett, J. F.,
R. M. Goldschmidt,
L. E. Lawrence,
B. Foleno,
R. Chen,
J. P. Demers,
S. Johnson,
R. Kanojia,
J. Fernandez,
J. Bernstein,
L. Licata,
A. Donetz,
S. Huang,
D. J. Hlasta,
M. J. Macielag,
K. Ohemeng,
R. Frechette,
M. B. Frosco,
D. H. Klaubert,
J. M. Whiteley,
L. Wang, and J. A. Hoch.
1998.
Antibacterial agents that inhibit two-component signal transduction systems.
Proc. Natl. Acad. Sci. USA
95:5317-5322[Abstract/Free Full Text].
|
| 3.
|
Bergdoll, M. S., and P. M. Schlievert.
1984.
Toxic shock syndrome toxin.
Lancet
ii:691.
|
| 4.
|
Blomster-Hautamaa, D. A., and P. M. Schlievert.
1988.
Preparation of toxic shock syndrome toxin-1.
Methods Enzymol.
165:37-43[Medline].
|
| 5.
|
Bohach, G. A.,
D. J. Fast,
R. D. Nelson, and P. M. Schlievert.
1990.
Staphylococcal and streptococcal pyrogenic toxins involved in toxic shock syndrome and related illnesses.
Crit. Rev. Microbiol.
17:251-272[Medline].
|
| 6.
|
Cone, L. A.,
D. R. Woodard,
R. G. Byrd,
K. Schulz,
S. M. Kopp, and P. M. Schlievert.
1992.
A recalcitrant, erythematous, desquamating disorder associated with toxin-producing staphylococci in patients with AIDS.
J. Infect. Dis.
165:638-643[Medline].
|
| 7.
|
Freed, R. C.,
M. L. Evenson,
R. F. Reiser, and M. S. Bergdoll.
1982.
Enzyme-linked immunosorbent assay for detection of staphylococcal enterotoxins in foods.
Appl. Environ. Microbiol.
44:1349-1355[Abstract/Free Full Text].
|
| 8.
|
Kass, E. H.,
M. I. Kendrick,
Y. C. Tsai, and J. Parsonnet.
1987.
Interaction of magnesium ion, oxygen tension, and temperature in the production of toxic-shock-syndrome toxin-1 by Staphylococcus aureus.
J. Infect. Dis.
155:812-815[Medline].
|
| 9.
|
Laemmli, U. K.
1970.
Cleavage of structural proteins during the assembly of the head of bacteriophage T4.
Nature
227:680-685[CrossRef][Medline].
|
| 10.
|
Macielag, M. J.,
J. P. Demers,
S. A. Fraga-Spano,
D. J. Hlasta,
S. G. Johnson,
R. M. Kanojia,
R. K. Russell,
Z. Sui,
M. A. Weidner-Wells,
H. Werblood,
B. D. Foleno,
R. M. Goldschmidt,
M. J. Loeloff,
G. C. Webb, and J. F. Barrett.
1998.
Substituted salicylanilides as inhibitors of two-component regulatory systems in bacteria.
J. Med. Chem.
41:2939-2945[CrossRef][Medline].
|
| 11.
|
Marrack, P., and J. Kappler.
1990.
The staphylococcal enterotoxins and their relatives.
Science
248:1066[Free Full Text].
|
| 12.
|
Meissner, H. C., and D. Y. M. Leung.
1998.
Kawasaki syndrome, p. 1662-1666.
In
S. L. Gorbach, J. G. Bartlett, and N. R. Blackow (ed.), Infectious diseases. The W. B. Saunders Co., Philadelphia, Pa.
|
| 13.
|
Mishell, B. B., and R. I. Mishell.
1980.
Primary immunization in suspension cultures, p. 30-37.
In
B. B. Mishell, and S. M. Shiigi (ed.), Selected methods in cellular immunology. W. H. Freeman & Co., San Francisco, Calif.
|
| 14.
|
Nakano, M. M.,
P. Zuber,
P. Glaser,
A. Danchin, and F. M. Hulett.
1996.
Two-component regulatory proteins ResD-ResE are required for transcriptional activation of fnr upon oxygen limitation in Bacillus subtilis.
J. Bacteriol.
178:3796-3802[Abstract/Free Full Text].
|
| 15.
|
Sarafian, S. K., and S. A. Morse.
1987.
Environmental factors affecting toxic shock syndrome toxin-1 (TSST-1) synthesis.
J. Med. Microbiol.
24:75-81[Abstract].
|
| 16.
|
Schlievert, P. M.
1988.
Immunochemical assays for toxic shock syndrome toxin-1.
Methods Enzymol.
165:339-344[Medline].
|
| 17.
|
Schlievert, P. M., and D. A. Blomster.
1983.
Production of staphylococcal pyrogenic exotoxin type C: influence of physical and chemical factors.
J. Infect. Dis.
147:236-242[Medline].
|
| 18.
|
Schlievert, P. M.,
J. R. Deringer,
M. H. Kim,
S. J. Projan, and R. P. Novick.
1992.
Effect of glycerol monolaurate on bacterial growth and toxin production.
Antimicrob. Agents Chemother.
36:626-631[Abstract/Free Full Text].
|
| 19.
|
Shands, K. N.,
G. P. Schmid,
B. B. Dan,
D. Blum,
R. J. Guidotti,
N. T. Hargrett,
R. L. Anderson,
D. L. Hill,
C. V. Broome,
J. D. Band, and D. W. Fraser.
1980.
Toxic-shock syndrome in menstruating women: association with tampon use and Staphylococcus aureus and clinical features in 52 cases.
N. Engl. J. Med.
303:1436-1442[Abstract].
|
| 20.
|
Sun, G.,
E. Sharkova,
R. Chesnut,
S. Birkey,
M. F. Duggan,
A. Sorokin,
P. Pujic,
S. D. Ehrlich, and F. M. Hulett.
1996.
Regulators of aerobic and anaerobic respiration in Bacillus subtilis.
J. Bacteriol.
178:1374-1385[Abstract/Free Full Text].
|
| 21.
|
Taylor, D., and K. T. Holland.
1988.
Effect of dilution rate and Mg2+ limitation on toxic shock syndrome toxin-1 production by Staphylococcus aureus grown in defined continuous culture.
J. Gen. Microbiol.
134:719-723[Medline].
|
| 22.
|
Todd, J. K.,
B. H. Todd,
A. Franco-Buff,
C. M. Smith, and D. W. Lawellin.
1987.
Influence of focal growth conditions on the pathogenesis of toxic shock syndrome.
J. Infect. Dis.
155:673-681[Medline].
|
| 23.
|
Wagner, G.,
L. Bohr,
P. Wagner, and L. N. Petersen.
1984.
Tampon-induced changes in vaginal oxygen and carbon dioxide tensions.
Am. J. Obstet. Gynecol.
148:147-150[Medline].
|
| 24.
|
Wong, A. C., and M. S. Bergdoll.
1990.
Effect of environmental conditions on production of toxic shock syndrome toxin 1 by Staphylococcus aureus.
Infect. Immun.
58:1026-1029[Abstract/Free Full Text].
|
Journal of Clinical Microbiology, May 2000, p. 1797-1803, Vol. 38, No. 5
0095-1137/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Schlievert, P. M.
(2007). Chitosan Malate Inhibits Growth and Exotoxin Production of Toxic Shock Syndrome-Inducing Staphylococcus aureus Strains and Group A Streptococci. Antimicrob. Agents Chemother.
51: 3056-3062
[Abstract]
[Full Text]
-
Cook, E., Wang, X., Robiou, N., Fries, B. C.
(2007). Measurement of Staphylococcal Enterotoxin B in Serum and Culture Supernatant with a Capture Enzyme-Linked Immunosorbent Assay. CVI
14: 1094-1101
[Abstract]
[Full Text]
-
Fuchs, S., Pane-Farre, J., Kohler, C., Hecker, M., Engelmann, S.
(2007). Anaerobic Gene Expression in Staphylococcus aureus. J. Bacteriol.
189: 4275-4289
[Abstract]
[Full Text]
-
Hill, D. R., Brunner, M. E., Schmitz, D. C., Davis, C. C., Flood, J. A., Schlievert, P. M., Wang-Weigand, S. Z., Osborn, T. W.
(2005). In vivo assessment of human vaginal oxygen and carbon dioxide levels during and post menses. J. Appl. Physiol.
99: 1582-1591
[Abstract]
[Full Text]
-
Parsonnet, J., Hansmann, M. A., Delaney, M. L., Modern, P. A., DuBois, A. M., Wieland-Alter, W., Wissemann, K. W., Wild, J. E., Jones, M. B., Seymour, J. L., Onderdonk, A. B.
(2005). Prevalence of Toxic Shock Syndrome Toxin 1-Producing Staphylococcus aureus and the Presence of Antibodies to This Superantigen in Menstruating Women. J. Clin. Microbiol.
43: 4628-4634
[Abstract]
[Full Text]
-
Peterson, M. L., Ault, K., Kremer, M. J., Klingelhutz, A. J., Davis, C. C., Squier, C. A., Schlievert, P. M.
(2005). The Innate Immune System Is Activated by Stimulation of Vaginal Epithelial Cells with Staphylococcus aureus and Toxic Shock Syndrome Toxin 1. Infect. Immun.
73: 2164-2174
[Abstract]
[Full Text]
-
Pragman, A. A., Yarwood, J. M., Tripp, T. J., Schlievert, P. M.
(2004). Characterization of Virulence Factor Regulation by SrrAB, a Two-Component System in Staphylococcus aureus. J. Bacteriol.
186: 2430-2438
[Abstract]
[Full Text]
-
Yarwood, J. M., Bartels, D. J., Volper, E. M., Greenberg, E. P.
(2004). Quorum Sensing in Staphylococcus aureus Biofilms. J. Bacteriol.
186: 1838-1850
[Abstract]
[Full Text]
-
Kikuchi, K., Takahashi, N., Piao, C., Totsuka, K., Nishida, H., Uchiyama, T.
(2003). Molecular Epidemiology of Methicillin-Resistant Staphylococcus aureus Strains Causing Neonatal Toxic Shock Syndrome-Like Exanthematous Disease in Neonatal and Perinatal Wards. J. Clin. Microbiol.
41: 3001-3006
[Abstract]
[Full Text]
-
Yarwood, J. M., McCormick, J. K., Paustian, M. L., Orwin, P. M., Kapur, V., Schlievert, P. M.
(2002). Characterization and Expression Analysis of Staphylococcus aureus Pathogenicity Island 3. IMPLICATIONS FOR THE EVOLUTION OF STAPHYLOCOCCAL PATHOGENICITY ISLANDS. J. Biol. Chem.
277: 13138-13147
[Abstract]
[Full Text]
-
Yarwood, J. M., McCormick, J. K., Paustian, M. L., Kapur, V., Schlievert, P. M.
(2002). Repression of the Staphylococcus aureus Accessory Gene Regulator in Serum and In Vivo. J. Bacteriol.
184: 1095-1101
[Abstract]
[Full Text]
-
Masalha, M., Borovok, I., Schreiber, R., Aharonowitz, Y., Cohen, G.
(2001). Analysis of Transcription of the Staphylococcus aureus Aerobic Class Ib and Anaerobic Class III Ribonucleotide Reductase Genes in Response to Oxygen. J. Bacteriol.
183: 7260-7272
[Abstract]
[Full Text]
-
Yarwood, J. M., McCormick, J. K., Schlievert, P. M.
(2001). Identification of a Novel Two-Component Regulatory System That Acts in Global Regulation of Virulence Factors of Staphylococcus aureus. J. Bacteriol.
183: 1113-1123
[Abstract]
[Full Text]